Aclarion Announces CLARITY Trial for Nociscan Now Fully
2 days ago · Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine.
Aclarion
NOCISCAN – The first, evidence-supported, SaaS platform to leverage MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine.
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
2 days ago · Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine.
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded
2 days ago · Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE ...
Aclarion’s Nociscan AI Plays Key Role in Advanced Understanding …
Sep 27, 2024 · Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be …
Aclarion Announces Completion of First Nociscan Exams in …
Sep 10, 2024 · Nociscan was selected for use in the study to help evaluate how magnetic resonance spectroscopy (MRS) biomarkers can identify patient improvement following treatment.
Aclarion's Nociscan Solution to Play Key Role in Groundbreaking …
Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain.
Publication Supports Nociscan as a Gold Standard for ... - Aclarion
Feb 23, 2024 · Aclarion’s proprietary decision-support tool, Nociscan, is the first evidence-supported SaaS platform to non-invasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain.
Aclarion Announces Completion of First Nociscan Exams in
Sep 10, 2024 · Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response. LIFEHAB is a Randomized Controlled Trial in Norway Comparing Lumbar Interbody Fusion Surgery With Multidisciplinary Rehabilitation.
Aclarion Announces Northwestern Medicine as Initial Site for …
19 hours ago · Aclarion’s Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine.
- Some results have been removed